Moneycontrol
HomeNewsOpinionMedPlus’ own branded product business needs close monitoring by investors

MedPlus’ own branded product business needs close monitoring by investors

R. Sree Ram   •

Success of the private label pharma products can improve MedPlus’ profitability and accelerate generic drug adoption in India

Customer retention is vital for the long-term success of the private label business

To read the full story,

Subscribe to Moneycontrol PRO
  • Ad-free Experience
  • Access Exclusive Stories
  • Weekly Investment Ideas
  • Daily Technical Calls

Are you a PRO subscriber? Sign In

What Do You Get

  • Ad free Experience

    Seamless navigation, faster responses.

  • Expert Perspective

    Explore 230+ exclusive editorials every month

  • +

    Uncover Insights from World-Renowned Experts and Journalists

  • Actionable Insights

    40+ weekly investment ideas + 3 to 4 daily technical calls

  • Virtual Events

    Exclusive Live Webinars for Expert Trading & Investment Strategies!

  • Newsletters

    Stay ahead with daily and weekly insights

View Offers

Unlock exclusive discounts